Quantitative Assessment of CYP1A1*2A Variations With Oral Carcinoma Susceptibility: Evidence From 1,438 Cases and 2,086 Controls

REFERENCES

• Zygogianni AG, Kyrgias G, Karakitsos P, Psyrri A, Kouvaris J, Kelekis N, Kouloulias V. Oral squamous cell cancer: early detection and the role of alcohol and smoking. Head Neck Oncol 2011;3:2.
   PubMedGoogle Scholar
• Reichart PA, Nguyen XH. Betel quid chewing, oral cancer and other oral mucosal diseases in Vietnam: a review. J Oral Pathol Med 2008;37:511–514.
   PubMed Web of Science ®Google Scholar
• Zhuo W, Wang Y, Zhuo X, Zhu Y, Wang W, Zhu B, Li D, Chen Z. CYP1A1 and GSTM1 polymorphisms and oral cancer risk: association studies via evidence-based meta-analyses. Cancer Invest 2009;27:86–95.
   PubMed Web of Science ®Google Scholar
• Zhou C, Zhou Y, Li J, Zhang Y, Jiang L, Zeng X, Feng X, Wang Z. The Arg194Trp polymorphism in the X-ray repair cross-complementing group 1 gene as a potential risk factor of oral cancer: a meta-analysis. Tohoku J Exp Med 2009;219:43–51.
   PubMed Web of Science ®Google Scholar
• Niu Y, Hu Y, Wu M, Jiang F, Shen M, Tang C, Chen N. CYP2E1 Rsa I/Pst I polymorphism contributes to oral cancer susceptibility: a meta-analysis. Mol Biol Rep 2012;39:607–612.
   PubMed Web of Science ®Google Scholar
• Zhuo XL, Li Q, Zhou Y, Cai L, Xiang ZL, Yuan W, Zhang XY. Study on TP53 codon 72 polymorphisms with oral carcinoma susceptibility. Arch Med Res 2009;40:625–634.
   PubMed Web of Science ®Google Scholar
• Boffetta P. Biomarkers in cancer epidemiology: an integrative approach. Carcinogenesis 2010;31:121–126.
   PubMed Web of Science ®Google Scholar
• Klaunig JE, Kamendulis LM, Hocevar BA. Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol 2010;38:96–109.
   PubMed Web of Science ®Google Scholar
• Guengerich FP, Shimada T. Activation of procarcinogens by human cytochrome P450 enzymes. Mutat Res 1998;400:201–213.
   PubMed Web of Science ®Google Scholar
• Zhou SF, Liu JP, Chowbay B. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab Rev 2009;41:89–295.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557–560.
   PubMed Web of Science ®Google Scholar
• Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719–748.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177–188.
   PubMed Web of Science ®Google Scholar
• Munafo MR, Clark TG, Flint J. Assessing publication bias in genetic association studies: evidence from a recent meta-analysis. Psychiatry Res 2004;129:39–44.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629–634.
   PubMed Web of Science ®Google Scholar
• Nair U, Bartsch H. Metabolic polymorphisms as susceptibility markers for lung and oral cavity cancer. IARC Sci Publ 2001;154:271–290.
   PubMedGoogle Scholar
• Varela-Lema L, Taioli E, Ruano-Ravina A, Barros-Dios JM, Anantharaman D, Benhamou S, Boccia S, Bhisey RA, Cadoni G, Capoluongo E, Chen CJ, Foulkes W, Goloni-Bertollo EM, Hatagima A, Hayes RB, Katoh T, Koifman S, Lazarus P, Manni JJ, Mahimkar M, Morita S, Park J, Park KK, Pavarino Bertelli EC, de Souza Fonseca Ribeiro EM, Roy B, Spitz MR, Strange RC, Wei Q, Ragin CC. Meta-analysis and pooled analysis of GSTM1 and CYP1A1 polymorphisms and oral and pharyngeal cancers: a HuGE-GSEC review. Genet Med 2008;10:369–384.
   PubMed Web of Science ®Google Scholar
• Bartsch H, Rojas M, Nair U, Nair J, Alexandrov K. Genetic cancer susceptibility and DNA adducts: studies in smokers, tobacco chewers, and coke oven workers. Cancer Detect Prev 1999;23:445–453.
   PubMedGoogle Scholar
• Sikdar N, Mahmud SA, Paul RR, Roy B. Polymorphism in CYP1A1 and CYP2E1 genes and susceptibility to leukoplakia in Indian tobacco users. Cancer Lett 2003;195:33–42.
   PubMed Web of Science ®Google Scholar
• Mahimkar MB, Samant TA, Kannan S, Patil T. Influence of genetic polymorphisms on frequency of micronucleated buccal epithelial cells in leukoplakia patients. Oral Oncol 2010;46:761–766.
   PubMed Web of Science ®Google Scholar
• Matthias C, Jahnke V, Fryer AA, Strange RC. Influence of glutathione s-transferase and cytochrome p450 polymorphisms on prognosis of head and neck cancer. Laryngorhinootologie 2002;81:406–412.
   PubMed Web of Science ®Google Scholar
• Worrall SF, Corrigan M, High A, Starr D, Matthias C, Wolf CR, Jones PW, Hand P, Gilford J, Farrell WE, Hoban P, Fryer AA, Strange RC. Susceptibility and outcome in oral cancer: preliminary data showing an association with polymorphism in cytochrome P450 CYP2D6. Pharmacogenetics 1998;8:433–439.
   PubMedGoogle Scholar
• Chatterjee S, Chakrabarti S, Sengupta B, Poddar S, Biswas D, Sengupta S, Talukder G. Prevalence of CYP1A1 and GST polymorphisms in the population of northeastern India and susceptibility of oral cancer. Oncol Res 2009;17:397–403.
   PubMed Web of Science ®Google Scholar
• Masood N, Kayani MA, Malik FA, Mahjabeen I, Baig RM, Faryal R. Genetic variation in carcinogen metabolizing genes associated with oral cancer in Pakistani population. Asian Pac J Cancer Prev 2011;12:491–495.
   PubMed Web of Science ®Google Scholar
• Matthias C, Bockmuhl U, Jahnke V, Jones PW, Hayes JD, Alldersea J, Gilford J, Bailey L, Bath J, Worrall SF, Hand P, Fryer AA, Strange RC. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers. Pharmacogenetics 1998;8:91–100.
   PubMedGoogle Scholar
• Sharma R, Panda NK, Khullar M. Hypermethylation of carcinogen metabolism genes, CYP1A1, CYP2A13 and GSTM1 genes in head and neck cancer. Oral Dis 2010;16:668–673.
   PubMed Web of Science ®Google Scholar
• Matthias C, Bockmuhl U, Jahnke V, Harries LW, Wolf CR, Jones PW, Alldersea J, Worrall SF, Hand P, Fryer AA, Strange RC. The glutathione S-transferase GSTP1 polymorphism: effects on susceptibility to oral/pharyngeal and laryngeal carcinomas. Pharmacogenetics 1998;8:1–6.
   PubMedGoogle Scholar
• Tanimoto K, Hayashi S, Yoshiga K, Ichikawa T. Polymorphisms of the CYP1A1 and GSTM1 gene involved in oral squamous cell carcinoma in association with a cigarette dose. Oral Oncol 1999;35:191–196.
   PubMed Web of Science ®Google Scholar
• Sato M, Sato T, Izumo T, Amagasa T. Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer. Carcinogenesis 1999;20:1927–1931.
   PubMed Web of Science ®Google Scholar
• Sreelekha TT, Ramadas K, Pandey M, Thomas G, Nalinakumari KR, Pillai MR. Genetic polymorphism of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer. Oral Oncol 2001;37:593–598.
   PubMed Web of Science ®Google Scholar
• Kao SY, Wu CH, Lin SC, Yap SK, Chang CS, Wong YK, Chi LY, Liu TY. Genetic polymorphism of cytochrome P4501A1 and susceptibility to oral squamous cell carcinoma and oral precancer lesions associated with smoking/betel use. J Oral Pathol Med 2002;31:505–511.
   PubMed Web of Science ®Google Scholar
• Gronau S, Koenig-Greger D, Jerg M, Riechelmann H. GSTM1 enzyme concentration and enzyme activity in correlation to the genotype of detoxification enzymes in squamous cell carcinoma of the oral cavity. Oral Dis 2003;9:62–67.
   PubMed Web of Science ®Google Scholar
• Gattas GJ, de Carvalho MB, Siraque MS, Curioni OA, Kohler P, Eluf-Neto J, Wunsch-Filho V. Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer. Head Neck 2006;28:819–826.
   PubMed Web of Science ®Google Scholar
• Anantharaman D, Chaubal PM, Kannan S, Bhisey RA, Mahimkar MB. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Carcinogenesis 2007;28:1455–1462.
   PubMed Web of Science ®Google Scholar
• Cha IH, Park JY, Chung WY, Choi MA, Kim HJ, Park KK. Polymorphisms of CYP1A1 and GSTM1 genes and susceptibility to oral cancer. Yonsei Med J 2007;48:233–239.
   PubMed Web of Science ®Google Scholar
• Losi-Guembarovski R, Colus IM, De Menezes RP, Poliseli F, Chaves VN, Kuasne H, Leichsenring A, Guembarovski AL, Oliveira BW, Ramos G, Cavalcanti TC, Mizuno LT, Cavalli IJ, Ribeiro EM. Lack of association among polymorphic xenobiotic-metabolizing enzyme genotypes and the occurrence and progression of oral carcinoma in a Brazilian population. Anticancer Res 2008;28:1023–1028.
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Dhar S, Sengupta B, Ghosh A, De M, Roy S, Chakrabarti S. Polymorphisms of CYP1A1, GSTM1 and GSTT1 loci as the genetic predispositions of oral cancers and other oral pathologies: tobacco and alcohol as risk modifiers. Indian J Clin Biochem 2010;25:260–272.
   Google Scholar
• Cordero K, Espinoza I, Caceres D, Roco A, Miranda C, Squicciarini V, Santander P, Lee K, Saavedra I, Quiñones L. Oral cancer susceptibility associated with the CYP1A1 and GSTM1 genotypes in Chilean individuals. Oncol Lett 2010;1:549–553.
   PubMed Web of Science ®Google Scholar
• Thakkinstian A, McElduff P, D'Este C, Duffy D, Attia J. A method for meta-analysis of molecular association studies. Stat Med 2005;24:1291–1306.
   PubMed Web of Science ®Google Scholar
• Tobias A. Assessing the influence of a single study in the meta-analysis estimate. Stata Techn Bull 1999;8:15–17.
   Google Scholar
• Zhuo WL, Wang Y, Zhuo XL, Zhu B, Zhu Y, Chen ZT. Polymorphisms of CYP1A1 and GSTM1 and laryngeal cancer risk: evidence-based meta-analyses. J Cancer Res Clin Oncol 2009;135:1081–1090.
   PubMed Web of Science ®Google Scholar
• Shaik AP, Jamil K, Das P. CYP1A1 polymorphisms and risk of prostate cancer: a meta-analysis. Urol J 2009;6:78–86.
   PubMed Web of Science ®Google Scholar
• Zhan P, Wang Q, Qian Q, Wei SZ, Yu LK. CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: an updated meta-analysis and review. J Exp Clin Cancer Res 2011;30: 99.
   PubMedGoogle Scholar
• Sergentanis TN, Economopoulos KP, Choussein S, Vlahos NF. Cytochrome P450 1A1 (CYP1A1) gene polymorphisms and cervical cancer risk: a meta-analysis. Mol Biol Rep 2012;39:6647–6654.
   PubMed Web of Science ®Google Scholar
• Zhuo WL, Zhang YS, Wang Y, Zhuo XL, Zhu B, Cai L, Chen ZT. Association studies of CYP1A1 and GSTM1 polymorphisms with esophageal cancer risk: evidence-based meta-analyses. Arch Med Res 2009;40:169–179.
   PubMed Web of Science ®Google Scholar
• Sergentanis TN, Economopoulos KP. Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 2010;122:459–469.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Wang JJ, Sun L, Li HL. Association between CYP1A1 polymorphism and colorectal cancer risk: a meta-analysis. Mol Biol Rep 2012;39:3533–3540.
   PubMed Web of Science ®Google Scholar
• Guo R, Guo X. Quantitative assessment of the associations between CYP1A1 polymorphisms and gastric cancer risk. Tumour Biol 2012;33:1125–1132.
   PubMed Web of Science ®Google Scholar
• Lee CC, Chien SH, Hung SK, Yang WZ, Su YC. Effect of individual and neighborhood socioeconomic status on oral cancer survival. Oral Oncol 2012;48:253–261.
   PubMed Web of Science ®Google Scholar
• Adeyemi BF, Olusanya AA, Lawoyin JO. Oral squamous cell carcinoma, socioeconomic status and history of exposure to alcohol and tobacco. J Natl Med Assoc 2011;103:498–502.
   PubMed Web of Science ®Google Scholar
• Zhang ZJ, Hao K, Shi R, Zhao G, Jiang GX, Song Y, Xu X, Ma J. Glutathione S-transferase M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) null polymorphisms, smoking, and their interaction in oral cancer: a HuGE review and meta-analysis. Am J Epidemiol 2011;173:847–857.
   PubMed Web of Science ®Google Scholar
• Supic G, Jovic N, Kozomara R, Zeljic K, Magic Z. Interaction between the MTHFR C677T polymorphism and alcohol–impact on oral cancer risk and multiple DNA methylation of tumor-related genes. J Dent Res 2011;90:65–70.
   PubMed Web of Science ®Google Scholar